GTR Home > Tests > Search results - Neurofibromatosis, type 1

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 2521 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states
More locations

GTR test search results for C0027831[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 63 tests for 1 condition in 34 labs

CExpanded RASopathy Panel (14 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (14)

CNeurofibromatosis type I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNF1/SPRED1 Sequencing and Deletion/Duplication on Blood

Lab: Medical Genomics Laboratory Department of Genetics UAB Birmingham, Alabama, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHereditary Pheochromocytoma and Paraganglioma Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (14)

CRASOPATHY-RELATED SYNDROME

Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (9)
Total targets (13)

CTier 2: Hereditary Lymphoma Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (14)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CCancer NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (43)
Total targets (35)

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CHereditary Paraganglioma-Pheochromocytoma Syndrome NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (11)
Total targets (11)

CNeurofibromatosis Type 1 and Related Disorders via the NF1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNF1 Sequencing and Deletion/Duplication on Blood

Lab: Medical Genomics Laboratory Department of Genetics UAB Birmingham, Alabama, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis Type 1 (NF1) Deletion/Duplication

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CNEUROFIBROMATOSIS TYPE 1 - NF1 gene

Test targets
Methods
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons

Showing 1 to 20 of 63 tests for 1 condition in 34 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.